NPR3
protein-codingnatriuretic peptide receptor 3, the group of DENN domain containing
Gene summary
This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
- NPRC
- ANPRC
- C5orf23
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~102.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859194
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859194
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0859194
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: The condition has been reported as including progressive dilation of the aortic root in some individuals, and awareness may allow surveillance and potential early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NPR3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001204375.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 72 | 3 | 75 | |||
| missense | 3 | 114 | 4 | 121 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 5 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 3 | 6 | 115 | 76 | 3 | 203 |
Highest pathogenic variant AF is 0.000009581782
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001191304.1 | 8 | MANE Select | |
| Ensembl | ENSP00000265074.8 | 8 | MANE Select | |
| RefSeq | NP_000899.1 | 8 | Standard | |
| RefSeq | NP_001191305.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| npr3 | Danio rerio | Structure: heart Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- miR-targeted genes in lymphocytes - TarBase
Biological Process
- skeletal system development
- osteoclast proliferation
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- negative regulation of adenylate cyclase activity
- phospholipase C-activating G protein-coupled receptor signaling pathway
Molecular Function
- protein binding
- G protein-coupled peptide receptor activity
- natriuretic peptide receptor activity
- peptide hormone binding
- chloride ion binding
Cellular Component
- integral component of plasma membrane
- protein-containing complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265074
- Coding exons
- 8
- Length
- 102644
- Individuals with no LoFs
- 124963
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 25
- Defined
- 124988
- p
- 0.000100
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.808 | 261 | 300 | 0.869 | 0.0000150 | 3489 |
| Missense (PolyPhen) | 87 | 112.94 | 0.77035 | 1246 | ||
| Synonymous | 0.491 | 118 | 125 | 0.944 | 0.00000665 | 1099 |
| Loss of Function | 2.23 | 12 | 23.7 | 0.506 | 0.00000134 | 268 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00012 | 0.00011 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity. {ECO:0000250|UniProtKB:P70180}.;
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- LoFtool
- 0.534
- RVIS EVS
- 0
- RVIS percentile EVS
- 53.73
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.432
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |